Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Corvus Pharmaceuticals Inc., 3 years.
Corvus Pharmaceuticals Inc.
Director
Oruka Therapeutics Inc.
Director
ICON plc
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Corvus Pharmaceuticals Inc. June 11, 202687.2%
-
Corvus Pharmaceuticals Inc. June 15, 202396.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 11, 2026 | ICON plc | Open-market sale | −87 | $162.72 | $14,157 |
| Aug 11, 2026 | ICON plc | Open-market sale | −97 | $163.77 | $15,886 |
| Aug 11, 2026 | ICON plc | Open-market sale | −590 | $164.47 | $97,037 |
| Aug 11, 2026 | ICON plc | Open-market sale | −67 | $165.51 | $11,089 |
| Aug 10, 2026 | ICON plc | Option exercise | +1,732 | — | — |
| May 15, 2023 | Corvus Pharmaceuticals Inc. | Open-market purchase | +10,000 | $2.45 | $24,500 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.